Giancarlo Troncone

Apr 24, 2024 | mdpi.com | Giancarlo Troncone |Massimo Barberis |Francesco Pepe |Riccardo Adorisio

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Sep 7, 2023 | onlinelibrary.wiley.com | Pasquale Pisapia |Umberto Malapelle |Philippe Vielh |Giancarlo Troncone

CONFLICT OF INTEREST STATEMENT Pasquale Pisapia has received personal fees (as speaker bureau) from Novartis for work performed outside of the current study. Umberto Malapelle has received personal fees (as a consultant and/or speaker bureau) from Boehringer Ingelheim, Roche, MSD, Amgen, Thermo Fisher Scientific, Eli Lilly, Diaceutics, GSK, Merck, AstraZeneca, Janssen, Diatech, Novartis, and Hedera unrelated to the current work.

Jun 9, 2023 | pubmed.ncbi.nlm.nih.gov | Giancarlo Troncone

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software

Jun 9, 2023 | onlinelibrary.wiley.com | Giancarlo Troncone

Graphical Abstract In the recent pandemic emergency caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), most activities in many areas of medicine have undergone a remarkable reduction. The health emergency has underlined the evolving role of cytopathology that is increasingly playing a remarkable role in providing oncologists and other physicians with timely information on personalised modern treatment of cancer diagnosed by cytological means.